Skip to main content
Premium Trial:

Request an Annual Quote

Newomics, Bruker Ink Comarketing Deal for Mass Spec Drug Discovery Solutions

NEW YORK – Newomics and Bruker announced on Wednesday a comarketing agreement around mass spectrometry solutions for drug discovery.

Under the agreement, the companies will market Berkeley, California-based Newomics' microflow-nanospray electrospray ionization products with Billerica, Massachusetts-based Bruker's maxis II and timsTOF Pro 2 mass spectrometers.

Newomics' core technology is its multinozzle emitter array (MEA) device, which splits sample flow into multiple smaller streams to improve sample ionization and mass spec performance.

"This comarketing agreement is built upon close collaborations between our R&D teams over the last several years," Michael Greig, director, pharma/biopharma Americas at Bruker, said in a statement. "We look forward to working with Newomics to create workflows using MnESI products on Bruker mass spectrometers for biologics and native mass spec applications."

"Our M3 emitter is the first commercial multinozzle emitter for mass spectrometry," Daojing Wang, Newomics' founder and CEO, said in a statement. "The new MnESI source directly addresses several key pain points in mass spectrometry analysis of native proteins, protein complexes, and oligonucleotides, and opens up new opportunities for biopharmaceutical and clinical research and development."

The agreement follows a comarketing deal Newomics signed with Thermo Fisher Scientific last year.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.